UK MHRA Scientific Advice on Pivotal Trial of NG13-2, a Novel Product for the Prevention of Chemotherapy-Induced Alopecia Gallery UK MHRA Scientific Advice on Pivotal Trial of NG13-2, a Novel Product for the Prevention of Chemotherapy-Induced Alopecia By Jack Whitby|2025-08-07T08:27:53+00:00July 11th, 2025|News, NG13| Read More
UK MHRA Scientific Advice on Pivotal Trial of NG11-2, a Novel Product for the Prevention of Oral Mucositis Gallery UK MHRA Scientific Advice on Pivotal Trial of NG11-2, a Novel Product for the Prevention of Oral Mucositis By Jack Whitby|2025-08-07T08:28:09+00:00June 20th, 2025|News, NG11| Read More
VasoDynamics receives PING Innovation Award 2025 Gallery VasoDynamics receives PING Innovation Award 2025 By Jack Whitby|2025-08-05T14:52:36+00:00May 23rd, 2025|News| Read More
NG11-2 Phase Ib clinical study in oral mucositis: UK MHRA confirms Scientific Advisory review meeting for June with feedback in late July 2025 Gallery NG11-2 Phase Ib clinical study in oral mucositis: UK MHRA confirms Scientific Advisory review meeting for June with feedback in late July 2025 By Chloe Atkinson|2025-08-05T10:23:46+00:00April 28th, 2025|News| Read More
NG11-2 Phase-Ib Clinical Study Results Summary Available Gallery NG11-2 Phase-Ib Clinical Study Results Summary Available By Chloe Atkinson|2025-06-09T09:17:16+00:00March 5th, 2025|News| Read More
NG11-2 Phase-Ib Clinical Study Report Complete Gallery NG11-2 Phase-Ib Clinical Study Report Complete By Chloe Atkinson|2025-05-20T09:41:22+00:00January 20th, 2025|News| Read More
New Year’s letter — Looking back on 2024 and our New Year’s Resolutions for 2025 Gallery New Year’s letter — Looking back on 2024 and our New Year’s Resolutions for 2025 By Chloe Atkinson|2025-01-03T10:10:53+00:00January 2nd, 2025|News| Read More
VasoDynamics Receives UK-Taiwan Collaborative R&D Grant Gallery VasoDynamics Receives UK-Taiwan Collaborative R&D Grant By Chloe Atkinson|2025-08-05T10:48:31+00:00November 25th, 2024|News| Read More
VasoDynamics Undertakes Pivotal Trial Scientific Advisory Meeting with Regulatory Authority in the Netherlands to Discuss Next Steps in NG11-2 Development Programme Gallery VasoDynamics Undertakes Pivotal Trial Scientific Advisory Meeting with Regulatory Authority in the Netherlands to Discuss Next Steps in NG11-2 Development Programme By Chloe Atkinson|2024-11-13T12:56:20+00:00October 18th, 2024|Clinical Development, News, NG11| Read More
VasoDynamics strengthens financial management with key appointment to enable progress to market access Gallery VasoDynamics strengthens financial management with key appointment to enable progress to market access By Bradley Shaw|2024-11-13T12:56:38+00:00September 3rd, 2024|Corporate Development, News| Read More
